Y Mabs Therapeutics Company Profile Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Y mabs therapeutics company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Y Mabs Therapeutics Company Profile Get Rating Today - Breaking & Trending Today

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Rating) have earned an average rating of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price among […] ....

United States , Y Mabs Therapeutics Company Profile Get Rating , Polar Capital Holdings Plc , Y Mabs Therapeutics Inc , Blackrock Inc , Dimensional Fund Advisors , Y Mabs Therapeutics , Get Rating , Capital Holdings Plc , Street Corp , Abs Therapeutics , Abs Therapeutics Company Profile , Nasdaq Ymab ,

Analysts Set Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Target Price at $31.60

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Rating) has been assigned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month price […] ....

United States , Hong Kong , Dekabank Deutsche Girozentrale , Y Mabs Therapeutics Company Profile Get Rating , Y Mabs Therapeutics Inc , Hong Kong Ltd , Royal Bank , Y Mabs Therapeutics , Get Rating , Marketbeat Ratings , Abs Therapeutics , Kong Ltd , Bank Deutsche Girozentrale , Abs Therapeutics Company Profile , Nasdaq Ymab ,